^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CK-102

    i
    Associations
    News
    Trials
    Company:
    Fortress, Teva
    Drug class:
    PARP1 inhibitor, PARP2 inhibitor
    Related drugs:
    Associations
    News
    Trials